Brian Rini
MD
Chief of Clinical Trials, Vanderbilt-Ingram Cancer Center
👥Biography 个人简介
Brian Rini has been a central figure in RCC therapeutics for over two decades, leading pivotal trials of anti-angiogenic and immunotherapy agents. He has contributed significantly to belzutifan clinical development and combination strategies. His work on treatment sequencing and biomarker development has optimized outcomes for advanced kidney cancer patients.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Brian Rini 的研究动态
Follow Brian Rini's research updates
留下邮箱，当我们发布与 Brian Rini（Vanderbilt University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment